Logo-npj
J Nephropharmacol. 2024;13(1): e11648.
doi: 10.34172/npj.2023.11648

Scopus ID: 85179369374
  Abstract View: 2069
  PDF Download: 952

Letter to Editor

Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology

Samaneh Zandifar 1 ORCID logo, Sadaf Farnam Nia 1 ORCID logo, Rastina Mehrani 2 ORCID logo, Bina Bakhshaei 3 ORCID logo, Samin Karamian 4* ORCID logo, Sina Bagheri 5 ORCID logo, Ali Ghorbani 5, Sina Bakhshaei 6* ORCID logo

1 Nickan Research Institute, Isfahan, Iran
2 School of Medicine, St George University, Grenada
3 Neurology Department, Median Klinik NRZ, Wiesbaden, Germany
4 Emergency Department, Parsian Hospital, Shahrekord, Iran
5 Internal Medicine Department, UHS Southwest Medical Education Consortium Temecula, CA, USA
6 Cardiology Department, UHS Southwest Medical Education Consortium Temecula, CA, USA
*Corresponding Authors: Samin Karamian, Email: karamian.samin@yahoo.com; Sina Bakhshaei, Email: sina.bakhshaei@uhsinc.com

Implication for health policy/practice/research/medical education:

Reverse cardio-oncology addressed the risk of ensuing cancer in individuals with heart disease. It is imperative to collaborate oncology with cardiology to effectively prevent and treat related diseases.

Please cite this paper as: Zandifar S, Farnam Nia S, Mehrani R, Bakhshaei B, Karamian S, Bagheri S, Ghorbani A, Bakhshaei S. Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology. J Nephropharmacol. 2024;13(1):e11648. DOI: 10.34172/npj.2023.11648.

First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.


Full Text View:

Your browser does not support the canvas element.